Fresh Recalls

FDAClass II · Drug · Recall D-0742-2026 · Recalled July 29, 2026

Divalproex Sodium Delayed-Release Tablets recall — Bionpharma Inc.

Agency report date: July 29, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Divalproex Sodium Delayed-Release Tablets
Company / brand
Bionpharma
Lot / serial / date codes
Lot# 704C003, Exp. 12/31/2028
Distribution
US Nationwide.
Agency product description and boundaries

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Presence of Foreign Tablets/Capsules

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Divalproex Sodium Delayed-Release Tablets

3. Open the official notice or contact

Official recall ID
D-0742-2026
Brand
Bionpharma
Classification
Class II
Units affected
N/A
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Princeton, NJ, United States
Firm address
400 Alexander Park Ste 2-4b, N/A, 08540-6539

Identifying details (verbatim from the notice)

Product codes / lots
Lot# 704C003, Exp. 12/31/2028
Distribution
US Nationwide.
Firm notified the public via
Letter
FDA event ID
99316
Recall initiated
June 26, 2026
FDA classified
August 6, 2026
FDA report date
July 29, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page